RecruitingPhase 3NCT07621809
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Sponsor: Novartis Pharmaceuticals
Jackson, TN · Memphis, TN · +18 more sites